Firstly, while it is established that saturated fatty acids (SFAs) can activate the NF-κB pathway, the precise molecular mechanisms and intermediary molecules involved in this activation process within prostate cancer cells remain unclear. This evidence concerns the gene NFKB1 and Familial prostate cancer.